Study for prevention of autoimmune non-insulin-dependent diabetes mellitus with sitagliptin (SPAN-S)
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Sitagliptin (Primary) ; Pioglitazone
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SPAN-S
- 16 Jun 2016 Planned End Date changed from 31 Dec 2020 to 31 Dec 2015.
- 30 Dec 2013 Planned End Date changed from 31 Dec 2018 to 31 Dec 2020 as reported by University Hospital Medical Information Network - Japan.
- 03 Dec 2012 Planned End Date changed to 1 Dec 2018 as reported by University Hospital Medical Information Network - Japan.